ICMP
XBI icon

Integrated Capital Management (Pennsylvania)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Integrated Capital Management (Pennsylvania)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-145,340
Closed -$4.25M – 93
2023
Q1 		$4.25M Buy
+145,340
New +$12.1M 3.87% 11

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return

Integrated Capital Management (Pennsylvania)'s XBI Position: Q2 2023 in Review

Integrated Capital Management (Pennsylvania) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 145,340 shares — an estimated $4.25M sold.

Integrated Capital Management (Pennsylvania) first reported a position in XBI in Q1 2023 and held it in 1 quarter. The position peaked at $4.25M in Q1 2023. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

  • Integrated Capital Management (Pennsylvania) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
  • Integrated Capital Management (Pennsylvania) sold 145,340 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $4.25M.
  • Integrated Capital Management (Pennsylvania) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 1 quarter.
  • Integrated Capital Management (Pennsylvania)'s State Street SPDR S&P Biotech ETF position peaked at $4.25M in Q1 2023.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Integrated Capital Management (Pennsylvania)'s 13F filing for Q2 2023, filed 31 Jul 2023.